For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Product Information
Phase Detail
Yarra SEC-X300 Phase
Yarra SEC-X300 GFC columns can be used for monoclonal antibodies (mAbs), antibody aggregation, antibody drug conjugates (ADCs), and biosimilars

Yarra SEC-X300 Phase

With a wide molecular weight range (10K – 700KDa) and high efficiency, Yarra SEC-X300 columns are well suited for the ultra-high-resolution separation and characterization of HMW biomolecules and aggregation studies including the following on UHPLC and HPLC systems:

  • monoclonal antibodies (mAbs)
  • antibody aggregation
  • antibody drug conjugates (ADCs)
  • biosimilars

Because Yarra SEC-X300 columns typically operate at backpressures below 3,500 psi, they can deliver improved performance (greater resolution, better peak shape and faster analysis time) for existing 3µm and 5µm GFC/SEC column methods on HPLC systems.

Yarra SEC-X300 Documents

Showing 1-3 of 3 results